Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$7.04 - $11.7 $4.82 Million - $8.01 Million
-684,630 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$9.98 - $18.04 $2.96 Million - $5.34 Million
-296,225 Reduced 30.2%
684,630 $7.3 Million
Q2 2020

Aug 14, 2020

SELL
$7.49 - $15.16 $549,346 - $1.11 Million
-73,344 Reduced 6.96%
980,855 $14.9 Million
Q1 2020

May 15, 2020

SELL
$4.62 - $18.74 $272,090 - $1.1 Million
-58,894 Reduced 5.29%
1,054,199 $8.78 Million
Q4 2019

Feb 14, 2020

BUY
$14.6 - $18.13 $411,442 - $510,921
28,181 Added 2.6%
1,113,093 $18.8 Million
Q3 2019

Nov 14, 2019

SELL
$16.62 - $23.92 $651,088 - $937,066
-39,175 Reduced 3.49%
1,084,912 $20.1 Million
Q2 2019

Aug 14, 2019

BUY
$17.79 - $22.88 $248,544 - $319,656
13,971 Added 1.26%
1,124,087 $25.7 Million
Q1 2019

May 15, 2019

BUY
$11.76 - $22.15 $1.98 Million - $3.72 Million
168,073 Added 17.84%
1,110,116 $23.3 Million
Q4 2018

Feb 14, 2019

BUY
$10.42 - $21.94 $2.58 Million - $5.43 Million
247,528 Added 35.64%
942,043 $10.8 Million
Q3 2018

Nov 14, 2018

BUY
$20.4 - $24.6 $115,994 - $139,875
5,686 Added 0.83%
694,515 $15.9 Million
Q2 2018

Aug 14, 2018

BUY
$19.02 - $24.95 $906,188 - $1.19 Million
47,644 Added 7.43%
688,829 $15.4 Million
Q1 2018

May 15, 2018

SELL
$22.55 - $29.9 $6.61 Million - $8.76 Million
-293,067 Reduced 31.37%
641,185 $14.7 Million
Q4 2017

Feb 14, 2018

BUY
$18.0 - $30.0 $1.33 Million - $2.21 Million
73,770 Added 8.57%
934,252 $24.5 Million
Q3 2017

Nov 14, 2017

BUY
$21.1 - $25.15 $18.2 Million - $21.6 Million
860,482
860,482 $19.3 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $168M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.